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Introduction
Genetic model systems have provided crucial insight into the
molecular mechanisms of apoptosis. Caspases, the critical
effector proteases of apoptosis, were first identified in a screen
for C. elegans mutants unable to undergo developmental
programmed cell death (Yuan et al., 1993). The inhibitor of
apoptosis (IAP) family of anti-apoptotic proteins were
originally described in insect viruses, and later found to be
essential regulators of apoptosis in Drosophila (Crook et al.,
1993). Clearly, many of the elements of the apoptotic
machinery are highly conserved throughout higher animals.
However, there is also considerable controversy about how
similar the pathways to execution are between mammals and
invertebrates. Here, we highlight some of the mechanistic
similarities and apparent differences between the activation and
regulation of C. elegans, Drosophila and mammalian apoptotic
pathways.
Caspases are highly conserved and share common
regulatory domains
The caspase proteases are the central executioners in most
apoptotic cell deaths (Cryns and Yuan, 1998). Initiator
caspases, usually distinguished by long regulatory pro-
domains, are activated in response to a variety of apoptotic
signals, including engagement of extracellular receptors by
death ligands such as Fas, damage to cellular components, or
breaches of mitochondrial integrity. Once active, the initiator
caspases can cleave and thereby activate the effector caspases
that go on to cleave a range of other targets, including structural
proteins in the cell, pro-apoptotic proteins that are activated by
cleavage, and anti-apoptotic proteins that are inactivated by
cleavage.
The role of caspases in apoptosis was first identified in the
nematode. The C. elegans Ced-3 caspase is required for all
programmed somatic cell deaths in the worm (Yuan et al.,
1993). It is present in an inactive pro-form in healthy cells and
is activated through binding to the pro-apoptotic regulator Ced-
4 (Chinnaiyan et al., 1997a; Seshagiri and Miller, 1997; Wu
et al., 1997). Homotypic interactions between a caspase
recruitment domain (CARD) in Ced-4 and a similar motif in
the pro-domain of Ced-3 cause Ced-3 to oligomerize. This is
thought to promote juxtaposition of adjacent Ced-3 molecules,
consequent intermolecular cleavage and activation of the
protease.
In Drosophila, the core effectors of the apoptotic process are
also the caspases. There are seven identified in the fly genome:
Dronc (also called Nc), Dredd, Strica, DrICE, Dcp-1, Decay
and Damm (Fraser and Evan, 1997; Song et al., 1997; Chen et
al., 1998; Dorstyn et al., 1999a; Dorstyn et al., 1999b;
Doumanis et al., 2001; Harvey et al., 2001). Surprisingly,
relatively little is known about most of these proteins. Dronc,
Dredd and Strica are classified as initiator caspases because
they have long pro-domains that appear to confer unique
aspects of regulation on each of these proteins. The other four
are classified as effector caspases.
Dronc is the best characterized of the fly caspases. Like
mammalian caspase-9, and C. elegans Ced-3, it has a CARD
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Studies in a wide variety of organisms have produced a
general model for the induction of apoptosis in which
multiple signaling pathways lead ultimately to activation of
the caspase family of proteases. Once activated, these
enzymes cleave key cellular substrates to promote the
orderly dismantling of dying cells. A broad similarity exists
in the cell death pathways operating in different organisms
and there is a clear evolutionary conservation of apoptotic
regulators such as caspases, Bcl-2 family members,
inhibitor of apoptosis (IAP) proteins, IAP antagonists and
caspase activators. Despite this, studies in Caenorhabditis
elegans, Drosophila and vertebrates have revealed some
apparent differences both in the way apoptosis is regulated
and in the way individual molecules contribute to the
propagation of the death signal. For example, whereas
cytochrome c released from mitochondria clearly promotes
caspase activation in vertebrates, there is no documented
role for cytochrome c in C. elegans apoptosis and its role
in Drosophila is highly controversial. In addition, the
apoptotic potency of IAP antagonists appears to be greater
in Drosophila than in vertebrates, indicating that IAPs may
be of different relative importance in different organisms.
Thus, although Drosophila, worms and humans share a
host of apoptotic regulators, the way in which they function
may not be identical.
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domain at its N-terminus (Dorstyn et al., 1999a). In all cases,
these domains appear to serve as docking sites for adaptor
proteins that promote the oligomerization and activation of the
bound caspases. As mentioned above, in the case of Ced-3, this
adaptor is Ced-4, by contrast, in the case of vertebrate caspase-
9, the adaptor is a protein known as Apaf-1 (Li et al., 1997;
Zou et al., 1997; Srinivasula et al., 1998). In both cases, the
oligomerized adaptor-caspase complex is referred to as the
apoptosome (Zou et al., 1999). In Drosophila, the fly Apaf-1
homolog Dark, also known as Hac-1 or dAPAF-1, binds to
Dronc, and is required for its activation (Kanuka et al., 1999;
Rodriguez et al., 1999; Zhou et al., 1999). However, as
described below, the regulation of Dark may differ from that
of mammalian Apaf-1.
Interestingly, Dronc shows unique substrate specificity,
cleaving both after aspartate, like other caspases, and glutamate
residues (Hawkins et al., 2000). Dronc autoprocesses itself by
cleaving at a glutamate residue in a Dark-dependent manner
(Muro et al., 2004).
During development, Dronc is transcriptionally regulated by
the steroid hormone ecdysone and is expressed in tissues
known to undergo apoptosis (Dorstyn et al., 1999a). Inhibition
of Dronc activity by RNA interference (RNAi) or a dominant-
negative Dronc mutant indicates that Dronc is important for a
significant amount of developmental cell death in the animal
(Quinn et al., 2000). Recent studies of Dronc-null flies confirm
this (Chew et al., 2004; Daish et al., 2004). In these animals,
developmental apoptosis in some tissues is blocked, whereas
in other tissues apoptosis proceeds normally. Stress-induced
apoptosis is dramatically reduced in the absence of Dronc.
Similarly, caspase-9-knockout mice show reduced apoptosis in
some tissues, although other developmental death appears
normal (Hakem et al., 1998; Kuida et al., 1998). These data
indicate that, both in mice and flies, the CARD-domain-
containing caspases, and presumably the apoptosome in
general, are required for some, but not all, developmental
apoptosis.
Dredd, another long pro-domain caspase, resembles
mammalian caspase-8 structurally and functionally (Chen et
al., 1998; Leulier et al., 2000). Most evidence suggests that the
major role of this caspase is in the innate immune response, in
which it is required for the processing of an NF-κB-like
transcription factor (Elrod-Erickson et al., 2000; Leulier et al.,
2000; Stoven et al., 2000; Georgel et al., 2001). However,
Dredd mutants also show defects in apoptosis (Chen et al.,
1998; Leulier et al., 2000; Georgel et al., 2001). Surprisingly,
Dredd is transcriptionally upregulated in response to cell death
signals, unlike most other caspases (Chen et al., 1998).
The other putative initiator caspase, Strica, contains a long
pro-domain that is rich in serine and threonine residues and
displays no sequence similarity to any mammalian caspase pro-
domains (Doumanis et al., 2001). Little is known about the role
of Strica in developmental or stress-induced apoptosis,
although it is expressed in tissues known to undergo apoptosis.
Dcp-1, Damm, DrICE and Decay are all classified as
effector caspases because they do not contain a long pro-
domain (Fraser and Evan, 1997; Song et al., 1997; Dorstyn et
al., 1999b; Harvey et al., 2001). There is some evidence that
these effector caspases do not have completely overlapping
functions and can play essential roles in certain types of
apoptosis. Dcp-1 is required for starvation-induced apoptosis
during early stages of oogenesis (Laundrie et al., 2003), and
depletion of DrICE inhibits apoptosis in S2 cell extracts (Fraser
et al., 1997). The absence of loss-of-function analyses for these
caspases precludes an accurate assessment of their roles in
developmental apoptosis.
Is the apoptosome function less-highly conserved?
The term apoptosome refers to a protein complex that activates
the initiator caspase(s) in response to an apoptotic signal. In its
simplest form in the worm, it consists of a Ced-3–Ced-4
complex. The pro-apoptotic activity of this complex is
normally held in check by sequestration of Ced-4 by Ced-9, an
anti-apoptotic factor related to mammalian Bcl-2-family
proteins (Hengartner and Horvitz, 1994; Chinnaiyan et al.,
1997b; Spector et al., 1997; Wu et al., 1997). When cells
receive apoptotic signals, Egl 1, a distant relative of the Bcl-2
family, is synthesized (Conradt and Horvitz, 1998). Binding of
Egl-1 to Ced-9 releases Ced-4, thereby allowing it to activate
Ced-3 (Yan et al., 2004). These changes are accompanied by
re-localization of Ced-4 from a Ced-9-tethered position on the
outside of the mitochondria to the outer nuclear membrane
(Chen et al., 2000). Thus, the worm apoptosome appears to be
directly regulated by Bcl-2-like proteins through a series of
mutually exclusive binding interactions. This process is
ultimately controlled at the transcriptional level, because
production of Egl-1 sets it in motion.
The ability of Ced-4 to activate Ced-3 is constitutive but is
blocked by the action of Ced-9. By contrast, the Ced-4-related
Apaf-1 protein of vertebrates does not have this innate ability
to activate caspase-9 in a resting cell (Li et al., 1997; Saleh et
al., 1999). This difference arises, at least in part, because of a
C-terminal extension on Apaf-1, absent from Ced-4, that
contains a series of WD-40 repeats. Removal of these repeats
yields a protein that has similar properties to Ced-4, and can
oligomerize and activate caspase-9 in a constitutive fashion
(Srinivasula et al., 1998; Hu et al., 1999). The WD-40 repeats
are thought to regulate Apaf-1 function negatively through
intramolecular interactions with N-terminal portions of the
molecule to produce a closed, inactive conformation (Hu et al.,
1999). Thus, unlike Ced-4, Apaf-1 is held inactive by self-
inhibition, rather than by association with an anti-apoptotic
Bcl-2-family member (Newmeyer et al., 2000). When Apaf-1
is in the inactive state, its CARD domain is apparently masked,
which prevents recruitment, oligomerization and consequent
activation of caspase-9.
In response to a variety of death signals, vertebrate cells
release cytochrome c from the intermembrane space of the
mitochondria into the cytoplasm (Liu et al., 1996; Kluck et al.,
1997; Zou et al., 1997). Once cytoplasmic, cytochrome c
interacts with Apaf-1 in a manner that is dependent on (though
not exclusively through) the WD-40 repeats (Benedict et al.,
2000). To do so, it must contain heme and, therefore, have
come from mitochondria and not a newly synthesized
cytoplasmic pool (Yang et al., 1997). Once bound to
holocytochrome c (and dATP), Apaf-1 undergoes a
conformational change, leading to exposure of the CARD
domain and subsequent binding of caspase-9. Interestingly, the
Apaf-1–caspase-9 complex appears to act as a holoenzyme:
continued activation of caspase-9 depends upon its continued
association with Apaf-1 rather than proteolytic processing
Journal of Cell Science 118 (9)
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(Rodriguez and Lazebnik, 1999; Boatright et al., 2003). Thus,
unlike effector caspases, caspase-9 does not require cleavage
for activation, and an uncleavable caspase-9 retains enzymatic
activity (Stennicke et al., 1999).
Cain et al. (Cain et al., 1999; Cain et al., 2000) have reported
that productive, cytochrome-c-driven oligomerization of the
Apaf-1–caspase-9 complex leads to formation of a 700 kDa
complex containing Apaf-1, caspase-9 and the caspase-9-
activated effector caspase-3 (and potentially other proteins,
such as IAPs). In cell lysates supplemented with cytochrome c
and dATP, Apaf-1 and caspase-9 are also detectable in a 1.4
MDa complex, although this complex is largely inactive in
processing caspase-3 and may or may not exist in intact cells.
Within cells, Apaf-1 does not appear to undergo any notable
shift in subcellular localization upon activation (unlike Ced-4),
but instead appears to be cytoplasmic in both healthy and dying
cells (Chen et al., 2000; Hausmann et al., 2000).
The Drosophila Apaf-1 protein Dark also has an N-terminal
CARD domain, a central domain homologous to Ced-4, and a
series of WD-40 repeats. Given its WD-40 repeats, Dark might
also be activated by cytochrome c released from mitochondria.
Indeed, initial reports demonstrated that Dark can be
immunoprecipitated in association with cytochrome c and that
this association depends upon the WD-40 repeats (Kanuka et
al., 1999; Rodriguez et al., 1999). Subsequent work consistent
with this idea demonstrated that a shift in the gel filtration
profile of the sole CARD-domain-containing initiator caspase
in flies, Dronc, can be induced by addition of cytochrome c to
cultured BG2 Drosophila cell lysates (Dorstyn et al., 2002).
Despite biochemical evidence implicating cytochrome c in
Dark activation, functional evidence for this has been patchy,
at best. Although purified cytochrome c from a variety of
sources (including Drosophila) can activate caspases when
added to cell lysates prepared from vertebrate cells, lysates
from Drosophila cultured S2 cells are notably refractory to
cytochrome c addition. Miura and co-workers have observed
some degree (~2-fold increase) of caspase activation in
embryonic fly lysates upon cytochrome c addition and,
strikingly, this is absent from lysates prepared from Dark-
deficient embryos (Kanuka et al., 1999). Stimulation of caspase
activity by cytochrome c has also been reported in extracts
primed for apoptosis (Dorstyn et al., 2004). However, although
one group reported that apoptotic stimuli induce the exposure
of a normally masked epitope on fly cytochrome c (Varkey et
al., 1999), multiple labs have failed to observe any clear release
of cytochrome c from the mitochondria into the cytoplasm on
induction of apoptosis in S2 cells (Zimmermann et al., 2002;
Dorstyn et al., 2004).
Additional doubts concerning the involvement of fly
cytochrome c in apoptosis have arisen from reports that
knocking down cytochrome c by RNAi in S2 cells does not
alter apoptosis. Green and co-workers showed that double-
stranded (ds)RNA directed against the cyt-c-p cytochrome c
transcript (which apparently downregulates both of the
cytochrome c proteins in Drosophila, Cyt-c-d and Cyt-c-p),
abrogates neither stress nor macromolecular-synthesis-
inhibitor-induced apoptosis, whereas dsRNA directed at Dark
does protect SL2 cells from these death stimuli (Zimmermann
et al., 2002). More recently, Kumar and co-workers have
silenced both of the cytochrome c variants and found that
neither cycloheximide-induced apoptosis in BG2 cells nor
ecdysone-induced death of l(2)mbn cells is markedly affected
(Dorstyn et al., 2004). By contrast, genetic data support a role
for cytochrome c in developmental apoptosis in at least one
tissue. A P-element insertion in one of the fly cytochrome c
genes (cyt-c-d) results in a defect in caspase activation and a
failure of caspase-dependent spermatid individualization
(Arama et al., 2003). Further work is needed to determine
whether this defect can be rescued by restoration of Cyt-c-d
alone or whether effects on nearby genes contribute to the
phenotype (Huh et al., 2004). Other studies have demonstrated
that a 50% reduction in the gene dosage of one or both
cytochrome c genes has no detectable affect on developmental
apoptosis (Dorstyn et al., 2004). Zygotic deletion of both genes
also has no obvious effect on embryonic apoptosis. Similarly,
only relatively subtle defects in apoptosis are observed in
embryos lacking Dark or Dronc (Kanuka et al., 1999;
Rodriguez et al., 1999; Zhou et al., 1999; Chew et al., 2004).
However, Drosophila embryos often have large amounts of
maternally contributed gene products, and the lack of
embryonic phenotypes in cytochrome c, Dark and Dronc
zygotic mutants might simply reflect the maternal contribution.
Given these issues and remaining gaps in our knowledge, we
cannot yet say definitively that Drosophila and vertebrate
Apaf-1 proteins operate in fundamentally different ways.
The Bcl-2 family as regulators of apoptosome
function
In vertebrates, Bcl-2-family proteins do not directly regulate
Apaf-1 but instead regulate release of cytochrome c from the
mitochondria, either positively or negatively (Fig. 1) (Kluck et
al., 1997; Yang et al., 1997). Anti-apoptotic members of the
family, including Bcl-2, Bcl-xL, Bcl-w and Boo/Diva, are able
to heterodimerize with pro-apoptotic Bcl-2-family members.
The latter can be divided into two subgroups: those containing
multiple Bcl-2-homology (BH) domains (e.g. Bax, Bak, Bok)
and those containing a single BH3 domain (the BH3-only
proteins, such as Bid, Bad, Noxa, Puma and Bim). Bax and
Bak can be activated by the BH3-only proteins either through
direct binding (e.g. tBid binds to Bax) or by BH3-only proteins
binding to and neutralizing anti-apoptotic family members that
would otherwise hold the multi-domain Bax and Bak proteins
in check (reviewed by Gross et al., 1999).
The anti-apoptotic action of Bcl-2-family members is
exerted largely at the mitochondria or the endoplasmic
reticulum, membrane association being mediated by a C-
terminal hydrophobic tail (Chen-Levy and Cleary, 1990; Janiak
et al., 1994). The membrane-anchoring domain of multi-
domain pro-apoptotic family members can confer constitutive
mitochondrial localization (as in the case of Bak) or be masked
prior to receipt of an apoptotic signal (e.g. Bax) (Wolter et al.,
1997; Nechushtan et al., 1999). Indeed, activation of Bax
is associated with both a conformational change and
translocation to mitochondria. Although Bak is also likely to
undergo a conformational change and appears to oligomerize
prior to induction of cytochrome c release, its activation is not
accompanied by an overt shift in subcellular localization
(Korsmeyer et al., 2000; Mikhailov et al., 2003; Wei et al.,
2000).
In vertebrates, apoptosis can be controlled transcriptionally
through induction of BH3-only proteins (e.g. Noxa and Puma)
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(Oda et al., 2000; Nakano and Vousden, 2001). However, these
proteins may also be sequestered intracellularly in inactive
forms and liberated through a variety of post-translational
mechanisms for promoting apoptosis (reviewed by Gross et al.,
1999).
Thus far, two Bcl-2-family members have been identified in
flies. These include the pro-apoptotic Debcl (also called Drob-
1, dBorg-1 and dBok) and the Buffy/dBorg-2, which has
been reported to have anti-apoptotic activity but lacks the
BH4 domain characteristic of its anti-apoptotic mammalian
counterparts (Brachmann et al., 2000; Colussi et al., 2000;
Igaki et al., 2000; Zhang et al., 2000; Quinn et al., 2003).
Characterization of these proteins has yielded somewhat
conflicting results. Although some investigators report that
overexpression of Debcl increases caspase activity, others have
suggested that Debcl-induced cell death is caspase independent
(it is unaffected by either p35 or zVAD inhibitors of caspases)
(Colussi et al., 2000; Igaki et al., 2000; Zimmermann et al.,
2002).
When expressed heterologously in mammalian cells, Debcl
can induce cytochrome c release from mitochondria, but it has
not been reported to do so in fly cells (Zhang et al., 2000).
Moreover, its C-terminal hydrophobic tail, which presumably
confers mitochondrial localization, appears to be important for
its pro-apoptotic activity (Igaki et al., 2000). Thus, Debcl might
kill cells by compromising mitochondrial function, entirely
bypassing any Dark/caspase pathway. In support of this,
Zimmerman et al. reported that knocking down Dark has no
marked effect on Debcl-induced cell death (Zimmermann et
al., 2002). By contrast, Colussi et al. reported that the rough-
eye phenotype resulting from UAS-Debcl expression in the eye
is suppressed in Dark hypomorphic flies (Colussi et al., 2000)
Journal of Cell Science 118 (9)
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Fig. 1. Models of apoptosome regulation. (A) In vertebrate cells, a variety of apoptotic stimuli induce release of cytochrome c from the
mitochondria. Once released, cytochrome c binds to Apaf-1, promoting a conformational change that leads to the exposure of the CARD
domain and consequent recruitment of pro-caspase-9 into the active oligomerized apoptosome; caspase-9 can then cleave and activate effector
caspases. Cytochrome c release from the mitochondria is promoted by pro-apoptotic Bcl-2-family members such as Bax and Bak and is
antagonized by anti-apoptotic members of the family such as Bcl-2 and Bcl-xL. Red rectangles, Apaf-1; light-blue circles, caspase-9; green
stars, cytochrome c. (B) In Drosophila cells, it is possible that cytochrome c, or some other intramitochondrial factor (represented here by
brown triangles) is released from mitochondria in response to apoptotic stimuli, to promote the activation of the Dark/Dronc apoptosome (red
rectangles and blue circles, respectively). This might stimulate oligomerization or enhance activation of the already oligomerized structure.
(C) If the fly Bcl-2-family members do not act at the level of cytochrome c release from the mitochondria as in vertebrates, it is possible that
pro-apoptotic Debcl protein (yellow rectangles) interacts in some way with the apoptosome to promote its activation. (D) By analogy to the
worm system, it is possible that the anti-apoptotic Bcl-2-family protein, Buffy, binds to and inhibits the apoptosome (either at the mitochondrial
surface or elsewhere). One possible scenario is that pro-apoptotic Debcl facilitates apoptosome activation by dimerizing with and thereby
removing Buffy from the apoptosome. (E) The C. elegans apoptosome is held in check by binding of Ced-9 to Ced-4. This repression is
relieved following Egl-1 production and interaction with Ced-9. Red bars, Ced-4; light-blue circles, Ced-3.
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and by the caspase inhibitor p35. These differences
might well reflect different complements of co-factors
in cultured S2/BG2 cells and the whole animal.
However, they do suggest that Debcl can activate both
caspase-dependent and caspase-independent modes of
cell death. One possible scenario is that the caspase-
dependent pathway involves Debcl-induced activation
of Dark, which might occur either by release of a Dark-
activating factor from the mitochondria (if not
cytochrome c, then perhaps some other factor), through
a direct interaction with Dark or through an indirect
interaction (see below).
IAPs as critical caspase inhibitors
Virtually all Drosophila cells undergo rapid apoptosis
in the absence of the DIAP1 protein (Goyal et al., 2000;
Lisi et al., 2000; Yoo et al., 2002). DIAP1 is a member
of the IAP family of proteins first identified in insect
viruses as critical inhibitors of host cell apoptosis
(Crook et al., 1993). In flies and mammals, endogenous
IAPs bind to active caspases and inhibit their function
(reviewed by Salvesen and Duckett, 2002), but, in C.
elegans, no IAP-like protein has been found to play a
role in regulating apoptosis (Fraser et al., 1999). IAPs
can inhibit caspase function by binding of their
conserved baculoviral IAP repeat (BIR) domain to the
caspase active site, by promoting the degradation of
active caspases, or by sequestering the caspase away
from its substrates (Tenev et al., 2004). IAP BIR
domains also bind to a short IAP-binding motif (IBM)
at the processed N-terminus of several pro-apoptotic
proteins (Vucic et al., 1997; Vucic et al., 1998). In flies,
these pro-apoptotic proteins, Reaper, Grim, Hid and
Sickle, act as critical inhibitors of IAP activity (Goyal
et al., 2000; Lisi et al., 2000; Yoo et al., 2002). Binding
of the IBM proteins to the BIR domain prevents caspase
inhibition by competing for caspase binding and by
promoting IAP degradation (Chai et al., 2003; Holley
et al., 2002; Ryoo et al., 2002; Yoo et al., 2002; Tenev
et al., 2004; Yokokura et al., 2004) (Fig. 2).
In mammalian systems, the best characterized of the
IBM-containing proteins are SMAC/DIABLO and
OMI/HTRA2 (Du et al., 2000; Verhagen et al., 2000; Suzuki
et al., 2001; Hegde et al., 2002). These proteins are normally
sequestered in mitochondria and are released only in apoptotic
cells that have compromised mitochondrial integrity.
Mammalian cells also contain non-IBM IAP inhibitors, such
as ARTS (Gottfried et al., 2004). Unlike Reaper, Grim, Hid and
Sickle, the known mammalian IBM-containing proteins do not
appear to have potent autonomous apoptotic activity. Rather,
upon release from mitochondria, they enhance the action of
cytochrome c to achieve maximal caspase activation. Thus,
these proteins act quite far downstream in the induction of
apoptosis. This is in marked contrast to the central regulatory
role of the IBM proteins in flies. In the absence of the reaper,
grim and hid genes, developmental apoptosis is not initiated in
most tissues (White et al., 1994). The production of these IBM
proteins is subject to exquisite transcriptional regulation during
Drosophila development. Reaper, for example, appears to be
expressed in almost all of the cells fated to die during
embryonic development and is not expressed in most of the
cells fated to survive (White et al., 1994). Grim and Sickle
show similar regulation, although exhibit slightly more-limited
expression, whereas Hid is more broadly expressed and is
regulated at both the transcriptional and post-translational
levels (Grether et al., 1995; Chen et al., 1996; Bergmann et al.,
1998; Kurada and White 1998; Wing et al., 2002).
Inhibition of DIAP1 by IBM proteins or by knocking out or
knocking down the gene encoding DIAP1 is sufficient to initiate
apoptosis (Goyal et al., 2000; Lisi et al., 2000; Yoo et al., 2002;
Zimmermann et al., 2002). This suggests that caspases are
already activated in fly cells and are only held in check by IAP
binding, indicating that apoptosome-mediated activation of
caspases is not an essential regulatory step in Drosophila
apoptosis. Clearly, Dark is important for activating caspases.
The massive apoptosis in the absence of DIAP1 is partially
inhibited in the absence of Dark (Rodriguez et al., 2002;
Zimmermann et al., 2002). The most parsimonious explanation
DIAP1
Other IAPs
Rpr
Grim
Hid
Skl
Active
caspases
Mitochondrial factors?
Dark
Apoptosis
Fig. 2. Apoptosis through the fly’s eye. In our current understanding of
apoptosis in Drosophila, DIAP1 acts as a central brake on apoptosis,
inhibiting activated caspases (reviewed by Hay, 2000). Caspase binding to
DIAP1 can result in sequestration of the caspase away from its targets or in
caspase degradation. The IBM proteins Rpr, Grim, Hid and Skl compete with
caspases for binding to DIAP1 and promote apoptosis. Rpr and Grim can also
suppress DIAP1 translation (Holley et al., 2002; Yoo et al., 2002). This is the
fundamental mechanism of apoptosis induction in fly development, as well as
in response to stress such as DNA damage (red bars) (White et al., 1994;
Nordstrom et al., 1996; Brodsky et al., 2004). DIAP1 also has other
functions: it can promote its own degradation and the degradation of IBM
proteins (Hay, 2000). DIAP1 may also regulate the levels of other IAPs
(broken arrows and bars are speculative). Caspase activity also contributes to
DIAP1 degradation (Ditzel et al., 2003; Yokokura et al., 2004). No role for
mitochondrial factors has been definitively demonstrated in Drosophila
apoptosis, although Rpr and Grim can release cytochrome c in heterologous
systems (Thress et al., 1999; Claveria et al., 2004). Dark is required to
activate the apical caspase Dronc (Kanuka et al., 1999; Rodriguez et al.,
1999; Zhou et al., 1999), and could be regulated by cytochrome c, although
this has not been demonstrated. It is clear that the other IAP-like proteins in
flies, DIAP2, deterin and dBRUCE, can suppress apoptosis, but their role and
mechanism of regulation has yet to be fully explored (Hay et al., 1995; Jones
et al., 2000; Vernooy et al., 2002; Arama et al., 2003). Developmental and
other environmental inputs (open arrows) can influence the apoptotic pathway
at several points, including the transcription and activity of the IBM proteins,
the synthesis of Dark and some of the caspases, and the synthesis of some of
the IAPs (White et al., 1994; Zhou et al., 1999; Dorstyn et al., 1999a; Jiang et
al., 2000).
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for this is that Dark is normally constitutively active, producing
active caspases that are then inhibited by DIAP1.
Mammalian cells seem to be less sensitive to the levels of
IAPs than are insect cells. Knocking out XIAP, the most potent
anti-apoptotic mammalian IAP, has little or no effect on
apoptosis (Harlin et al., 2001). However, there is a clear
upregulation of cIAP1 and cIAP2 in the XIAP-null animals
that may explain the lack of a phenotype. Most data support a
role for mammalian IAPs as inhibitors of apoptosis acting
downstream of the apoptosis-initiating event. In support of this,
XIAP loss makes cells more sensitive to the induction of
apoptosis (Potts et al., 2003). Also, the known mammalian
IBM proteins show weak activity in triggering apoptosis in
some cells but potentiate other death signals (e.g. Arnt et al.,
2002; Li et al., 2004).
Is this apparent difference in the requirement for IAPs in
insect and mammalian systems simply a reflection of the
increased activation of Drosophila caspases by constitutively
active Dark? This seems unlikely, because DIAP1 is required
for viability even in the absence of Dark. Perhaps fly cells are
primed in multiple ways to undergo apoptosis more easily
than mammalian cells. This would be compatible with the
need for precise spatial and temporal control of apoptosis
during the rapid development of the organism. Alternatively,
perhaps the apparent differences are due to a weakness in our
ability to assess the role of IAPs in mammalian development,
owing to their redundancy and cross-regulation. Not only do
the functions of the 8 mammalian IAP-like proteins appear to
overlap, but there is evidence that IAPs can regulate the levels
of other IAPs at the level of protein degradation, creating the
potential for compensatory activity of other IAPs when one
or more is knocked out (Harlin et al., 2001) (J. Silke and D.
Vaux, personal communication; T. Yokokura and K.W.,
unpublished).
Conclusions and Perspectives: is the fly a worm
with wings?
Despite our efforts to shoehorn the fly into a worm or a
vertebrate model, perhaps the fly is neither flying nematode nor
human in terms of its apoptotic regulation. The major areas of
controversy appear to be the regulation of apoptosome activity
by cytochrome c and the role of the Bcl-2-family proteins.
Because the bulk of the data are primarily negative, the issue
of whether cytochrome c is involved in fly cell apoptosis may
not be entirely closed. Scrutiny of each line of evidence raises
some questions. For example, in experiments where purified
cytochrome c failed to elicit caspase activation in fly cell
lysates, were levels of the IAPs sufficiently high to ‘mop up’
and neutralize any incipiently activated caspases (and could
IAP levels be much higher in fly cell lysates than in vertebrate
cell lysates)? Perhaps the ability of cytochrome c to elicit
increased caspase responses in lysates primed for apoptosis
(Dorstyn et al., 2004) is due to decreased levels of DIAP1. If
the affinity of Dark for cytochrome c is high (as is the case for
Apaf-1), can knocking it down by RNAi reduce cytochrome c
levels sufficiently to disrupt caspase activation? Similarly,
might maternal pools of cytochrome c remaining in the zygotic
cytochrome c mutants be enough to support caspase activation?
What if cytochrome c is released from the intermembrane
space of the mitochondria in response to apoptotic stimuli but
remains tightly tethered to the outer membrane, rather than
being released to the cytoplasm? Because Dark and Dronc can
both reportedly associate with mitochondria, it is plausible that
an apoptosome is nucleated by membrane-tethered cytochrome
c. Perhaps Dark is even constitutively bound to cytochrome c
in fly cells (which would be consistent with the observation
that some cytochrome c is extra-mitochondrial even in living
cells) (Dorstyn et al., 2004) and a conformational change
occurs in cytochrome c to allow apoptotic activation of
Dark, explaining the observed alteration in cytochrome c
immunoreactivity (Varkey et al., 1999). Under these
circumstances, Dark-bound cytochrome c might be refractory
to the turnover necessary to rid cells of cytochrome c following
dsRNA treatment (or loss of maternal pools in the mutant
embryos). Because an active fly apoptosome assembled from
purified Dark and Dronc has not yet been reported, the
possibility that the isolated apoptosome (in the absence of
DIAP or other cellular factors) exhibits increased activity in
the presence of cytochrome c cannot be ruled out.
The presence of WD-40 repeats on Dark led many to assume
that Dark is more similar in function to Apaf-1 than to Ced-4.
It is interesting to note that one group has detected a truncated
form of Dark in embryos (Kanuka et al., 1999). This form lacks
the WD repeats and would be expected to behave more
similarly to Ced-4. However, if cytochrome c does not activate
Dark, it is attractive to consider the possibility that Dark has
the potential to be constitutively active but is, like Ced-4,
restrained by an anti-apoptotic Bcl-2-family protein.
Alternatively, a pro-apoptotic Bcl-2-family member might
somehow serve as a direct Dark activator (Fig. 1).
With regard to the possibility that the fly apoptosome more
precisely parallels the worm apoptosome, it is significant that
Dark, Dronc and Buffy have all been reported to localize to
mitochondria, which is analogous to the behavior of the worm
Ced-9–Ced-4–Ced-3 complex (Dorstyn et al., 2002b; Quinn et
al., 2003). However, this analogy breaks somewhat if one
considers the fact that Buffy does not look precisely like an
anti-apoptotic Bcl-2-family member and that at least one group
has observed pro-apoptotic, rather than anti-apoptotic, effects
of Buffy overexpression (Igaki and Miura, 2004). Furthermore,
no BH3-only protein has been discovered in the Drosophila
genome. Yet, it was only through very careful scrutiny (and
genetic implication) that Egl-1 was deduced to contain a BH3
domain. Moreover, the presumably pro-apoptotic Debcl [one
group has also seen pro-survival activity from this molecule
(Brachmann et al., 2000)] can heterodimerize with Buffy
(Brachmann et al., 2000; Quinn et al., 2003). This raises the
possibility that Buffy holds Dark/Dronc in check and full
activation is achieved by Debcl-induced removal of Buffy from
the complex.
It is possible that differences in apoptotic signaling in
Drosophila and vertebrates are only apparent, reflecting the
incomplete state of our knowledge of these pathways. Thus,
further genetic and biochemical analysis will be required to
determine exactly where flies land in the spectrum of apoptotic
regulation.
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Note added in proof
New analysis of embryos lacking both maternal and zygotic
Dronc shows that Dronc is required for almost all apoptosis in
the Drosophila embryo (Xu et al., 2005). 
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